Atlas Trials

Assessing the Risk of CMV Infection of the Renal Transplant About R + by Cellular Immunity Analyzed by the QuantiFERON ®-CMV Test.

Clinical trial NCT02064699 · TERMINATED

Trial details

NCT number
NCT02064699
Sponsor
University Hospital, Limoges
Status
TERMINATED
Study type
OBSERVATIONAL
Renal Transplant RecipientImmunized Against the Cytomegalovirus
Start date
2013-05-01
Primary completion
2017-12-13
Enrollment
75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.